Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005664809
Thu, 19.03.2026
Evotec SE
Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancer
Transformative moment in strategic protein degradation collaboration with Bristol Myers Squibb (BMS) aiming to establish new treatment paradigm in advanced clear [ … ]
Tue, 10.03.2026
Evotec SE
Evotec Announces ‘Horizon’ – Next Inflection in Its Strategic Transformation to Accelerate Growth and Promote Agility
Horizon advances multi-stage transformation initiated with Priority Reset in 2024 and establishes new operating model across three pillars: operations, science and commercial execution
Operations: Global footprint further str [ … ]
Thu, 08.01.2026
Evotec SE
Just – Evotec Biologics will optimize monoclonal antibodies (“mAbs”) and other biologic modalities
Investment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, immunogenicity, and stability, over the next three years
Hamburg, Germany, January 08, [ … ]
Thu, 01.01.2026
Evotec SE
Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment
Hamburg, Germany, January 1, 2026:
Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) toda [ … ]
